PYXS: Pyxis Oncology Inc

PYXS新闻

• 13:30 Pyxis Oncology: Better Runway Is Bullish For MICVO’s Remaining R&D (NASDAQ:PYXS)
• 17:06 12 Health Care Stocks Moving In Wednesday's Intraday Session
• 12:05 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
• 12:05 周三盘前交易时段中波动的12只医疗保健股票
• 06:56 Pyxis Oncology Prices $110M Offering Of 36,047,919 Shares At $2.90 With Common Warrants For 49,310,352 Shares At $3.50 Exercise Price
• 06:56 Pyxis Oncology以每股2.90美元定价1.100亿美元发行36,047,919股，并附带普通认股权证，可按每股3.50美元行权价认购49,310,352股
• 20:25 Pyxis Oncology Launches Public Offering Of Common Stock/Pre-Funded Warrants And Warrants To Fund MICVO Phase 3 Development; No Terms Disclosed
• 20:24 Pyxis Oncology Terminates $150M ATM Offering, Says As Of The Date Of This Supplement, We Have Not Sold Any Shares Of Our Common Stock Pursuant To The Sales Agreement
• 17:43 Pyxis Oncology: Setbacks Costing Nearly 2 Years Of Recovery (NASDAQ:PYXS)
• 09:35 Pyxis Oncology, Inc. (PYXS) Discusses MICVO Monotherapy Phase I Clinical Data in Head and Neck Squamous Cell Carcinoma - Slideshow (NASDAQ:PYXS) 2026-09-10
• 07:37 Pyxis Oncology, Inc. (PYXS) Discusses MICVO Monotherapy Phase I Clinical Data in Head and Neck Squamous Cell Carcinoma Transcript